This work is licensed under a
Creative Commons Attribution 4.0 International License
 H. Beger, Treatment of pancreatic cancer: challenge of the facts, World J Surg. 27 (2003) 1075-1084.
 V. Surlin et al., Prognostic factors in resectable pancreatic cancer, Rev. Med. Chir. Soc. Med. Nat. Iasi. 118 (2014) 924-931.
 R. Pezzilli, Screening tests for pancreatic cancer: searching for the early symptoms or the population at risk, Jop. 5 (2004) 240-242.
 E. Tamm, Diagnosis, staging, and surveillance of pancreatic cancer, AJR Am J Roentgenol. 180 (2003) 1311-1323.
 D. Timofte et al., Molecular factors with predictive value for the survival rate in pancreatic cancer: focusing on CA 19-9, Analele Ştiinţifice ale Universităţii Alexandru Ioan Cuza, Secţiunea Genetică şi Biologie Moleculară. 15 (2014) 21-26.
 D. Timofte et al., The relevance of some tumoral markers in patients with pancreatic cancer, Analele Ştiinţifice ale Universităţii Alexandru Ioan Cuza, Secţiunea Genetică şi Biologie Moleculară, 15 (2014) 51-58.
 D. Timofte et al., The relevance of some molecular markers in recurrent pancreatic cancer: focusing on CA 19-9 and cytokeratins, Rev. Med. Chir. Soc. Med. Nat. Iasi. 119 (2015) 730-737.
 D. Timofte et al., Studying the Post-Operatory and Molecular Modifications in the Chronic Pancreatitis and Pancreatic Cancer - The Importance of the Micronutrients and Pancreatic Enzyme Supplementation, International Letters of Natural Sciences. 47 (2015).DOI: 10.18052/www.scipress.com/ilns.47.89
 D. Timofte, L. Ionescu, L. Ochiuz, Mini-Review on the Glucose Metabolism Modifications after Pancreatic Resection, International Letters of Natural Sciences. 53 (2016) 65-71.DOI: 10.18052/www.scipress.com/ilns.53.65
 National Comprehensive Cancer Network, NCCN Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma, (2015).
 American Joint Committee on Cancer (AJCC) TNM staging system. American Cancer Society, (2013).
 S. Edge, D. Byrd, C. Compton CC, AJCC Cancer Staging Manual (ed 7th). New York: Springer; (2010).
 K. Bilimoria, D. Bentrem, C. Ko CY, Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database, Cancer. 110 (2007) 738-744.DOI: 10.1002/cncr.22852
 D. Michaud, Epidemiology of pancreatic cancer, Minerva Chir. 59 (2004) 99-111.
 M. Edderkaoui, E. Thrower, Smoking induced pancreatitis and pancreatic cancer, Pancreapedia: Exocrine Pancreas Knowledge Base, (2015).DOI: 10.3998/panc.2015.25
 D. Yadav, A. Lowenfels, The Epidemiology of Pancreatitis and Pancreatic Cancer. Gastroenterology. 144 (2013) 1252-1261.DOI: 10.1053/j.gastro.2013.01.068
 L. Wang, G. Yang, X. Lu, Z. Huang, H. Li, Pancreatic cancer mortality in China, World J Gastroenterol. 9 (2003) 1819–1823.
 S. Sener, Pancreatic cancer: a report of treatment and survival trends for 100, 313 patients diagnosed from 1985-1995, using the National Cancer Database, J. Am Coll. Surg. 189 (1999) 1-7.
 M. Del Chiaro, S. Presciuttini, L. Bertacca, A. Zerbi A, Clinical Pancreatic Cancer. HPB (Oxford). 7 (2005) 76–90.
 F. Greene, L. Sobin, The staging of cancer: a retrospective and prospective appraisal, CA Cancer J Clin. 58 (2008) 180–190.DOI: 10.3322/ca.2008.0001
 W. Nabil, Impact of Tumor Grade on Prognosis in Pancreatic Cancer: Should We Include Grade in AJCC Staging? Annals of Surgical Oncology. 17 (2010): 2312–2320.DOI: 10.1245/s10434-010-1071-7
 S. Chakraborty, S. Singh, Surgical resection improves survival in pancreatic cancer patients without vascular invasion- a population based study, Ann Gastroenterol. 26 (2013) 346–352.
 S. Yamada, T. Fujii, H. Sugimoto H, Pancreatic cancer with distant metastases: a contraindication for radical surgery? Hepatogastroenterology. 56 (2009) 881-885.